{{Rsnum
|rsid=3764563
|Gene=CYP4F8
|Chromosome=19
|position=15613392
|Orientation=minus
|GMAF=0.0652
|Gene_s=CYP4F8
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.8 | 18.6 | 2.7
| HCB | 89.8 | 9.5 | 0.7
| JPT | 95.6 | 4.4 | 0.0
| YRI | 87.7 | 11.6 | 0.7
| ASW | 94.7 | 5.3 | 0.0
| CHB | 89.8 | 9.5 | 0.7
| CHD | 90.8 | 9.2 | 0.0
| GIH | 42.4 | 49.5 | 8.1
| LWK | 91.7 | 8.3 | 0.0
| MEX | 93.1 | 5.2 | 1.7
| MKK | 95.5 | 4.5 | 0.0
| TSI | 83.3 | 15.7 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22228203
|Trait=None
|Title=A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
|RiskAllele=
|Pval=3E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}